Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline in Depression with Panic Spectrum
NCT00177996Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2001
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sertraline in major depressive disorder (MDD) (2 arms), sponsored by University of Pittsburgh. Primary endpoint: Somatic Symptoms Scale at 1 week. Started Oct 2001; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00177996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177996.